EUVIMEDEUVIMED entdecken
Open Access

On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies

Cheng-Han Yang, Guanghui Cheng, Ruitao Lin iD

Pharmaceutical Statistics · 2024

DOI: 10.1002/pst.2364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2024. Verfasst von Cheng-Han Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Bayes Theorem, Maximum Tolerated Dose, Dose-Response Relationship, Drug, Clinical Trials, Phase I as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Nature Science Foundation of China, NCI NIH HHS, GuangDong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Bayesian logistic regression method (BLRM) is a widely adopted and flexible design for finding the maximum tolerated dose in oncology phase I studies. However, the BLRM design has been criticized in the literature for being overly conservative due to the use of the overdose control rule. Recently, a discussion paper titled “Improving the performance of Bayesian logistic regression model with overall control in oncology dose‐finding studies” in Statistics in Medicine has proposed an overall control rule to address the “excessive conservativeness” of the standard BLRM design. In this short communication, we discuss the relative conservativeness of the standard BLRM design and also suggest a dose‐switching rule to further enhance its performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bayes TheoremMaximum Tolerated DoseDose-Response Relationship, DrugClinical Trials, Phase I as TopicAntineoplastic AgentsHumansLogistic ModelsNeoplasmsResearch Design

Stichwörter der Autor:innen

Bayesian logistic regression modeldose findingmaximum tolerated doseoverdose controlphase I trial

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Guangzhou Institute of International Finance, Guangzhou University, Guangzhou, Guangdong, China.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Ruitao Lin

Förderung

  • National Nature Science Foundation of China
  • NCI NIH HHS
  • GuangDong Basic and Applied Basic Research Foundation
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Cancer Institute

Zitieren

APA

Yang, C. H., Cheng, G., & Lin, R. (2024). On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2364

Vancouver

Yang CH, Cheng G, Lin R. On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies. Pharmaceutical Statistics. 2024. doi:10.1002/pst.2364

BibTeX
@article{Yang2024,
  author = {Yang, Cheng-Han and Cheng, Guanghui and Lin, Ruitao},
  title = {On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies},
  journal = {Pharmaceutical Statistics},
  year = {2024},
  doi = {10.1002/pst.2364}
}
Kostenlos starten →